Page last updated: 2024-08-17

dichloroacetic acid and Heritable Pulmonary Arterial Hypertension

dichloroacetic acid has been researched along with Heritable Pulmonary Arterial Hypertension in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, G; Boukouris, AE; Chow, K; Cupitt, J; Freed, DH; Gibbs, JSR; Gurtu, V; Howard, L; Kiely, DG; Kinnaird, A; Michelakis, ED; Nagendran, J; O'Regan, DP; Paterson, I; Thompson, RB; Watson, G; Webster, L; Wharton, J; White, C; Wilkins, MR; Wort, SJ; Zhao, L	1
Aboagye, EO; Ashek, A; Barnes, G; Cotroneo, E; Cupitt, J; Dabral, S; Dubois, O; El-Bahrawy, MA; Fang, W; Gibbs, JS; Gsell, W; He, JG; Howard, LS; Jones, H; Nguyen, QD; Pullamsetti, SS; Tomasi, G; Wang, L; Wilkins, MR; Zhao, L	1

Trials

2 trial(s) available for dichloroacetic acid and Heritable Pulmonary Arterial Hypertension

Article	Year
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. Science translational medicine, 2017, Oct-25, Volume: 9, Issue:413 Topics: Administration, Oral; Adolescent; Adult; Biomarkers; Dichloroacetic Acid; Familial Primary Pulmonary Hypertension; Female; Genetic Predisposition to Disease; Hemodynamics; Humans; Lung; Male; Middle Aged; Perfusion; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Sirtuin 3; Uncoupling Protein 2; Up-Regulation; Young Adult	2017
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation, 2013, Sep-10, Volume: 128, Issue:11 Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult	2013

Article

Year

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Science translational medicine, 2017, Oct-25, Volume: 9, Issue:413

Topics: Administration, Oral; Adolescent; Adult; Biomarkers; Dichloroacetic Acid; Familial Primary Pulmonary Hypertension; Female; Genetic Predisposition to Disease; Hemodynamics; Humans; Lung; Male; Middle Aged; Perfusion; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Sirtuin 3; Uncoupling Protein 2; Up-Regulation; Young Adult

2017

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.

Circulation, 2013, Sep-10, Volume: 128, Issue:11

Topics: Adult; Aged; Animals; Benzamides; Cell Division; Dichloroacetic Acid; Disease Models, Animal; Drug Monitoring; Familial Primary Pulmonary Hypertension; Female; Fibroblasts; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Indoles; Lung; Male; Middle Aged; Monocrotaline; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sunitinib; Young Adult

2013